Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/18/2025

Management of Hemodynamic Instability

Initial Management

  • For hemodynamically unstable patients, the American College of Cardiology recommends considering atropine for symptomatic bradycardia and implementing temporary pacing for refractory cases 1
  • The American Heart Association suggests synchronized cardioversion for hemodynamically unstable patients when other measures fail 2

Ongoing Management

  • The American College of Cardiology recommends considering beta-adrenergic agonists (isoproterenol, dopamine, dobutamine, or epinephrine) if symptoms persist in hemodynamically stable patients 1

Evaluation for Permanent Pacing

  • The American College of Cardiology recommends evaluating for permanent pacing if AV block persists despite medication discontinuation 1
  • The American Heart Association indicates that permanent pacemaker implantation is recommended for third-degree and advanced second-degree AV block at any anatomic level associated with bradycardia with symptoms 3

Special Considerations

  • The American Heart Association warns that non-dihydropyridine calcium channel antagonists are potentially harmful in patients with pre-excited AF (WPW syndrome) 4
  • The American College of Critical Care Medicine and the American Heart Association provide guidance on managing adverse effects from calcium channel blockers (CCBs), including:
  • Contraindications and precautions for CCBs:
  • For suspected CCB overdose or severe toxicity, the American College of Critical Care Medicine recommends administering IV calcium, implementing high-dose insulin therapy with glucose supplementation, using vasopressors (norepinephrine preferred) for shock, and considering lipid emulsion therapy for refractory cases 6